These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6538740)

  • 21. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with thromboxane synthetase inhibitor dazoxiben hydrochloride, (UK-37, 248-01).
    Randall MJ; Wilding RI
    Thromb Res; 1982 Dec; 28(5):607-16. PubMed ID: 6897751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dazoxiben on exercise performance in chronic stable angina.
    Reuben SR; Kuan P; Cairns J; Gyde OH
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):83S-86S. PubMed ID: 6402000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibition of thromboxane synthetase with dazoxiben - basis of its inhibitory effect on platelet adhesion.
    Menys VC; Davies JA
    Thromb Haemost; 1983 Apr; 49(2):96-101. PubMed ID: 6346575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.
    FitzGerald GA; Brash AR; Oates JA; Pedersen AK
    J Clin Invest; 1983 Oct; 72(4):1336-43. PubMed ID: 6355181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor.
    Bertelé V; Falanga A; Tomasiak M; Cerletti C; de Gaetano G
    Thromb Haemost; 1984 Feb; 51(1):125-8. PubMed ID: 6326343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the thromboxane synthetase inhibitor Dazoxiben (UK 37-248) on the metabolism of antipyrine in patients with enhanced platelet aggregation.
    Staiger C; Walter E; Wang NS; Schuhmacher E; de Vries J; Weber E
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):250-3. PubMed ID: 6540249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
    Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dazoxiben on platelet-vessel wall interaction.
    Davies JA; Menys VC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):45S-46S. PubMed ID: 6681703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
    Gresele P; Arnout J; Deckmyn H; Huybrechts E; Pieters G; Vermylen J
    J Clin Invest; 1987 Nov; 80(5):1435-45. PubMed ID: 2960694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental coronary artery thrombosis in the absence of thromboxane A2 synthesis: evidence for alternate pathways for coronary thrombosis.
    Hook BG; Schumacher WA; Lee DL; Jolly SR; Lucchesi BR
    J Cardiovasc Pharmacol; 1985; 7(1):174-81. PubMed ID: 2580139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved lactate extraction in dogs with coronary artery ligation following administration of a thromboxane synthetase inhibitor.
    Eddy LJ; Oei HH; Glenn TM
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):87-97. PubMed ID: 6682567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic protection of the reperfused canine endocardium by the thromboxane synthetase inhibitor, dazoxiben.
    Pieper GM; Farber NE; Gross GJ
    Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):13-22. PubMed ID: 3054935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.
    Patrignani P; Filabozzi P; Catella F; Pugliese F; Patrono C
    J Pharmacol Exp Ther; 1984 Feb; 228(2):472-7. PubMed ID: 6537977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition of thromboxane synthesis during experimental endotoxemia in the goat: effects on pulmonary haemodynamics and lung lymph flow.
    Harlan J; Winn R; Hildebrandt J; Harker L
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):123S-126S. PubMed ID: 6337602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2.
    Gresele P; Deckmyn H; Huybrechts E; Vermylen J
    Biochem Pharmacol; 1984 Jul; 33(13):2083-8. PubMed ID: 6430299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dazoxiben on arrhythmias and ventricular fibrillation induced by coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):87S-95S. PubMed ID: 6681710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A thromboxane synthetase inhibitor in Raynaud's phenomenon.
    Jones EW; Hawkey CJ
    Prostaglandins Leukot Med; 1983 Sep; 12(1):67-71. PubMed ID: 6356154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of dazoxiben, a selective thromboxane synthetase inhibitor, in the adult respiratory distress syndrome.
    Leeman M; Boeynaems JM; Degaute JP; Vincent JL; Kahn RJ
    Chest; 1985 Jun; 87(6):726-30. PubMed ID: 4039645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial impressions of dazoxiben in the treatment of the ischaemic limb.
    Raftery AT; Livesey S; Forty J
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):119S-121S. PubMed ID: 6681701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.